These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 22631039

  • 1. Treatment strategies for hemoglobin E beta-thalassemia.
    Olivieri NF.
    Blood Rev; 2012 Apr; 26 Suppl 1():S28-30. PubMed ID: 22631039
    [Abstract] [Full Text] [Related]

  • 2. HbE/β-thalassemia: basis of marked clinical diversity.
    Olivieri NF, Pakbaz Z, Vichinsky E.
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1055-70. PubMed ID: 21075280
    [Abstract] [Full Text] [Related]

  • 3. Hemoglobin E-beta-thalassemia: Progress report from the International Study Group.
    Premawardhena A, De Silver S, Arambepola M, Olivieri NF, Vichinsky EP, Merson L, Muraco G, Allen A, Fisher C, Peto T, Weatherall DJ.
    Ann N Y Acad Sci; 2005 Dec; 1054():33-9. PubMed ID: 16339649
    [Abstract] [Full Text] [Related]

  • 4. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD, Motta I.
    Hematology Am Soc Hematol Educ Program; 2017 Dec 08; 2017(1):278-283. PubMed ID: 29222267
    [Abstract] [Full Text] [Related]

  • 5. Optimal management of β thalassaemia intermedia.
    Taher AT, Musallam KM, Cappellini MD, Weatherall DJ.
    Br J Haematol; 2011 Mar 08; 152(5):512-23. PubMed ID: 21250971
    [Abstract] [Full Text] [Related]

  • 6. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
    Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.
    Ann N Y Acad Sci; 2005 Mar 08; 1054():250-6. PubMed ID: 16339672
    [Abstract] [Full Text] [Related]

  • 7. Clinical, hematological and molecular features in Thais with beta-Malay/beta-thalassemia and beta-Malay/HbE.
    Laosombat V, Wongchanchailert M, Sattayesevana B, Nopparatana C.
    Southeast Asian J Trop Med Public Health; 1997 Mar 08; 28 Suppl 3():106-9. PubMed ID: 9640610
    [Abstract] [Full Text] [Related]

  • 8. Emerging insights in the management of hemoglobin E beta thalassemia.
    Olivieri NF, Thayalsuthan V, O'Donnell A, Premawardhena A, Rigobon C, Muraca G, Fisher C, Weatherall DJ.
    Ann N Y Acad Sci; 2010 Aug 08; 1202():155-7. PubMed ID: 20712787
    [Abstract] [Full Text] [Related]

  • 9. Studies in haemoglobin E beta-thalassaemia.
    Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ.
    Br J Haematol; 2008 May 08; 141(3):388-97. PubMed ID: 18410572
    [Abstract] [Full Text] [Related]

  • 10. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.
    Jamsai D, Zaibak F, Vadolas J, Voullaire L, Fowler KJ, Gazeas S, Peters H, Fucharoen S, Williamson R, Ioannou PA.
    Genomics; 2006 Sep 08; 88(3):309-15. PubMed ID: 16631345
    [Abstract] [Full Text] [Related]

  • 11. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
    Uaprasert N, Satitthummanid S, Akkawat B, Sutcharitchan P, Rojnuckarin P.
    Thromb Res; 2019 Feb 08; 174():104-112. PubMed ID: 30584959
    [Abstract] [Full Text] [Related]

  • 12. Haemoglobin E beta thalassaemia in Sri Lanka.
    Premawardhena A, Fisher CA, Olivieri NF, de Silva S, Arambepola M, Perera W, O'Donnell A, Peto TE, Viprakasit V, Merson L, Muraca G, Weatherall DJ.
    Lancet; 2019 Feb 08; 366(9495):1467-70. PubMed ID: 16243092
    [Abstract] [Full Text] [Related]

  • 13. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D.
    Haematologica; 2006 May 08; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
    Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.
    J Clin Pathol; 2010 Feb 08; 63(2):147-50. PubMed ID: 20154037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Contemporary approaches to treatment of beta-thalassemia intermedia.
    Taher AT, Musallam KM, Karimi M, Cappellini MD.
    Blood Rev; 2012 Apr 08; 26 Suppl 1():S24-7. PubMed ID: 22631038
    [Abstract] [Full Text] [Related]

  • 18. Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia?
    Rees DC, Clegg JB, Weatherall DJ.
    Blood; 1998 Sep 15; 92(6):2141-6. PubMed ID: 9731073
    [Abstract] [Full Text] [Related]

  • 19. Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.
    Paritpokee N, Wiwanitkit V, Bhokaisawan N, Boonchalermvichian C, Preechakas P.
    Clin Lab; 2002 Sep 15; 48(11-12):631-4. PubMed ID: 12465748
    [Abstract] [Full Text] [Related]

  • 20. Hemoglobin E-beta thalassemia: factors affecting phenotype.
    Panigrahi I, Agarwal S, Gupta T, Singhal P, Pradhan M.
    Indian Pediatr; 2005 Apr 15; 42(4):357-62. PubMed ID: 15876597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.